Beijing Balance Medical Technology Co., Ltd.

38
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005X15
CNY
115.92
-2.09 (-1.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
497.00
368.00
293.00
250.00
180.00
145.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
497.00
368.00
293.00
250.00
180.00
145.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
147.00
127.00
128.00
135.00
74.00
29.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
151.00
129.00
122.00
129.00
83.00
47.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
367.00
269.00
211.00
220.00
133.00
77.00
Operating Profit (PBDIT) excl Other Income
130.00
98.00
81.00
30.00
46.00
67.00
Other Income
20.00
20.00
23.00
18.00
18.00
5.00
Operating Profit (PBDIT)
175.00
133.00
112.00
56.00
71.00
78.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
25.00
14.00
7.00
7.00
5.00
5.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
150.00
120.00
106.00
49.00
66.00
72.00
Provision for Tax
18.00
10.00
11.00
-1.00
10.00
10.00
Profit After Tax
146.00
115.00
95.00
51.00
56.00
63.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
1.06
0.84
0.70
0.38
0.42
0.47
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 35.04% vs 25.58% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 32.12% vs 21.06% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 15.76% vs 227.66% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 27.02% vs 21.11% in Dec 2023

Compare Profit and Loss Results of Beijing Balance Medical Technology Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
497.00
0
497.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
497.00
0
497.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
147.00
0
147.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
151.00
0
151.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
367.00
0
367.00
0%
Operating Profit (PBDIT) excl Other Income
130.00
0.00
130.00
0%
Other Income
20.00
0
20.00
0%
Operating Profit (PBDIT)
175.00
0
175.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
25.00
0
25.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
150.00
0
150.00
0%
Provision for Tax
18.00
0
18.00
0%
Profit After Tax
146.00
0
146.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.065
0
1.06
0%
Profit And Loss - Net Sales
Net Sales 497.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.04% vs 25.58% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 130.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 32.12% vs 21.06% in Dec 2023

Profit And Loss - Interest
Interest 0.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 15.76% vs 227.66% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 146.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 27.02% vs 21.11% in Dec 2023